These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 27543390)

  • 1. Ensemble-based docking: From hit discovery to metabolism and toxicity predictions.
    Evangelista W; Weir RL; Ellingson SR; Harris JB; Kapoor K; Smith JC; Baudry J
    Bioorg Med Chem; 2016 Oct; 24(20):4928-4935. PubMed ID: 27543390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods for docking small molecules to macromolecules: a user's perspective. 2. Applications.
    Campagna-Slater V; Therrien E; Weill N; Moitessier N
    Curr Pharm Des; 2014; 20(20):3360-72. PubMed ID: 23947644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ensemble-based docking using biased molecular dynamics.
    Campbell AJ; Lamb ML; Joseph-McCarthy D
    J Chem Inf Model; 2014 Jul; 54(7):2127-38. PubMed ID: 24881672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidating substrate promiscuity in the human cytochrome 3A4.
    Hayes C; Ansbro D; Kontoyianni M
    J Chem Inf Model; 2014 Mar; 54(3):857-69. PubMed ID: 24571781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic undocking and the quasi-bound state as tools for drug discovery.
    Ruiz-Carmona S; Schmidtke P; Luque FJ; Baker L; Matassova N; Davis B; Roughley S; Murray J; Hubbard R; Barril X
    Nat Chem; 2017 Mar; 9(3):201-206. PubMed ID: 28221352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Docking Using Quantum Mechanical-Based Methods.
    Aucar MG; Cavasotto CN
    Methods Mol Biol; 2020; 2114():269-284. PubMed ID: 32016899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural ensemble in computational drug screening.
    Fukunishi Y
    Expert Opin Drug Metab Toxicol; 2010 Jul; 6(7):835-49. PubMed ID: 20465522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ensemble Docking in Drug Discovery.
    Amaro RE; Baudry J; Chodera J; Demir Ö; McCammon JA; Miao Y; Smith JC
    Biophys J; 2018 May; 114(10):2271-2278. PubMed ID: 29606412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flexible receptor docking for drug discovery.
    Wong CF
    Expert Opin Drug Discov; 2015; 10(11):1189-200. PubMed ID: 26313123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ensemble docking of multiple protein structures: considering protein structural variations in molecular docking.
    Huang SY; Zou X
    Proteins; 2007 Feb; 66(2):399-421. PubMed ID: 17096427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based virtual screening of novel, high-affinity BRD4 inhibitors.
    Muvva C; Singam ER; Raman SS; Subramanian V
    Mol Biosyst; 2014 Jul; 10(9):2384-97. PubMed ID: 24976024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early phase drug discovery: cheminformatics and computational techniques in identifying lead series.
    Duffy BC; Zhu L; Decornez H; Kitchen DB
    Bioorg Med Chem; 2012 Sep; 20(18):5324-42. PubMed ID: 22938785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel antagonists of human neurotensin receptor 1 on the basis of ligand and protein structure.
    Zhang G; Wang K; Li XD; Zhang DL; Xu F
    Biomed Pharmacother; 2016 Dec; 84():147-157. PubMed ID: 27643557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docking simulations between drugs and HLA molecules associated with idiosyncratic drug toxicity.
    Hirayama N
    Drug Metab Pharmacokinet; 2017 Feb; 32(1):31-39. PubMed ID: 27964952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the challenges of protein flexibility in drug design.
    Antunes DA; Devaurs D; Kavraki LE
    Expert Opin Drug Discov; 2015 Dec; 10(12):1301-13. PubMed ID: 26414598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based drug metabolism predictions for drug design.
    Sun H; Scott DO
    Chem Biol Drug Des; 2010 Jan; 75(1):3-17. PubMed ID: 19878193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating drug-target association and dissociation mechanisms using metadynamics-based algorithms.
    Cavalli A; Spitaleri A; Saladino G; Gervasio FL
    Acc Chem Res; 2015 Feb; 48(2):277-85. PubMed ID: 25496113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward in silico structure-based ADMET prediction in drug discovery.
    Moroy G; Martiny VY; Vayer P; Villoutreix BO; Miteva MA
    Drug Discov Today; 2012 Jan; 17(1-2):44-55. PubMed ID: 22056716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
    Meanwell NA
    Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using reverse docking for target identification and its applications for drug discovery.
    Lee A; Lee K; Kim D
    Expert Opin Drug Discov; 2016 Jul; 11(7):707-15. PubMed ID: 27186904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.